Craniometaphyseal dysplasia, autosomal recessive type

Known as: Autosomal Recessive Craniometaphyseal Dysplasia, CMDR, Craniometaphyseal Dysplasia, Autosomal Recessive 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2016
012319732016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND In order to develop a more effective prophylactic HIV-1 vaccine it is important optimize the components, improve… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2017
2017
Background We report the first-in-human safety and immunogenicity evaluation of PENNVAX-G DNA/modified vaccinia Ankara-Chiang Mai… (More)
Is this relevant?
2017
2017
Motivation Detecting epistatic interactions in genome-wide association studies (GWAS) is a computational challenge. Such huge… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2016
2016
With the recent emergence of reports on resistant Gram-negative ‘superbugs’, infections caused by multidrug-resistant (MDR) Gram… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
The objective of this study was to characterize the temporal behavior of contaminant mass discharge, and the relationship between… (More)
Is this relevant?
2012
2012
The current study assessed the immunogenicity and protective efficacy of various prime-boost vaccine regimens in rhesus macaques… (More)
Is this relevant?
2012
2012
Heterologous priming and boosting with antigens expressed by DNA, viral vectors, or as proteins, are experimental strategies to… (More)
Is this relevant?
2012
2012
Prime-boost vaccination strategies against HIV-1 often include multiple variants for a given immunogen for better coverage of the… (More)
Is this relevant?
2010
2010
BACKGROUND We conducted a Phase I randomized, dose-escalation, route-comparison trial of MVA-CMDR, a candidate HIV-1 vaccine… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2009
2009
Recombinant modified vaccinia virus Ankara (rMVA) expressing HIV-1 genes are promising vaccine candidates. Toward the goal of… (More)
Is this relevant?